首页 | 本学科首页   官方微博 | 高级检索  
     

尤瑞克林治疗急性脑梗死的临床观察
引用本文:邓兵梅,刘雁,彭凯润,杨红军. 尤瑞克林治疗急性脑梗死的临床观察[J]. 脑与神经疾病杂志, 2009, 17(2): 104-106
作者姓名:邓兵梅  刘雁  彭凯润  杨红军
作者单位:广州军区广州总医院神经内科,广州,510010;广州军区广州总医院神经内科,广州,510010;广州军区广州总医院神经内科,广州,510010;广州军区广州总医院神经内科,广州,510010
基金项目:广州市科技攻关重点项目 
摘    要:目的观察尤瑞克林治疗急性脑梗死的疗效。方法将91例急性脑梗死患者随机分为治疗组和对照组,两组基础用药均为血栓通注射液500mg1/日+阿司匹林0.1g1/晚。其中治疗组46例,除基础用药外,另用尤瑞克林0.15PNAU加生理盐水250ml静滴1次/日;对照组45例仅用基础用药。使用美国国立卫生研究所脑卒中评分(NIHSS)和残疾指数(mRS Index)评价神经功能恢复情况。结果(1)治疗14天后,尤瑞克林治疗组的NIHSS评分、mRS评分较对照组有明显改善(P<0.05);治疗组有效率高于对照组(86.96%vs75.56%),差异有统计学意义(P<0.05)。(2)两组均未发生明显不良反应。结论尤瑞克林治疗急性脑梗死安全有效。

关 键 词:尤瑞克林  急性脑梗死  治疗

Case-control study of therapeutic effect of urinary kallidinogenase for acute cerebral infarction
DENG Bing-mei,LIU Yan,PENG Kai-run,YANG Hong-jun. Case-control study of therapeutic effect of urinary kallidinogenase for acute cerebral infarction[J]. Journal of Brain and Nervous Diseases, 2009, 17(2): 104-106
Authors:DENG Bing-mei  LIU Yan  PENG Kai-run  YANG Hong-jun
Affiliation:DENG Bing-mei,LIU Yan,PENG Kai-run,YANG Hong-jun . Departments of Neurology,Guangzhou General Hospital of Guangzhan Military Comm,,Guangzhou 510010,China
Abstract:Objective To evaluate the efficacy of human urinary kallidinogenase in treating patients with acute cerebral infarction. Methods Ninety-one patients with acute cerebral infarction were randomly divided into two groups in this study; the treatment group were given urinary kallidinogenase ,Xueshuantong injection and aspirin;and the control group were treated by Xueshuangtong injection and aspirin.The National Instiutes of Health Stroke Scale (NIHSS),mRS Index and therapeutic outcomes in the two groups were ad...
Keywords:Urinary Kallidinogenase  Acute Cerebral Infarction  Treatment  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号